Bill S-204 explained in plain English

On June 26, 2011, the Senate held its first reading for Bill S-204, an Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). This procedural step involved the introduction of the bill and related debate.

On September 28, 2011, the Senate of Canada convened for a sitting that included Senators' Statements, Routine Proceedings, Question Period, and Orders of the Day. During the sitting, Senators made statements on various topics including visible minorities in political leadership, the International Day for the Remembrance of the Slave Trade and its Abolition, and congratulations for a ninetieth birthday. Routine Proceedings saw the tabling of annual reports and the first reading of Bill S-2, an act respecting family homes on First Nation reserves. Question Period addressed issues such as the Anti-terrorism Act, the Canadian Wheat Board, international war criminals, and Canada's policy on Palestine's United Nations membership application. Under Orders of the Day, debate on several items was adjourned, including a motion to change Senate sitting times, the second reading of Bill S-204 (An Act to establish a national strategy for chronic cerebrospinal venous insufficiency), and a report on the Canadian Forest Sector. The Senate also continued debate on an inquiry concerning Aboriginal children in care in Manitoba.

This document records the Senate's debate at the second reading stage of Bill S-204. The main discussion focused on the bill's purpose to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI) treatments for multiple sclerosis patients. Senator Jane Cordy, the bill's sponsor, highlighted the need for Canadian clinical trials for CCSVI, shared personal stories of individuals affected by MS, and expressed concern over the government's slow progress in implementing previously announced initiatives like an MS registry and clinical trials. Other senators also raised discussions on various topics including visible minorities in politics, the remembrance of the slave trade, air transportation safety, the status of Université de Saint-Boniface, infanticide, the Anti-terrorism Act, the Canadian Wheat Board, international war criminals, the Israeli-Palestinian conflict, and the alarming number of Indigenous children in care in Manitoba.

On November 17, 2011, the Senate continued its second reading debate on Bill S-204, an Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). Senator A. Raynell Andreychuk indicated that she would complete her notes and speak to the bill on a subsequent Tuesday or Wednesday, and the debate was adjourned. The sitting also included other routine proceedings, question period, and debates on various other bills and inquiries.

On December 8, 2011, the Senate continued its second reading debate on Bill S-204, an Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). The debate focused on the potential connection between CCSVI and Multiple Sclerosis (MS), and the proposed "liberation procedure" as a treatment. Senators discussed the current state of research, Health Canada's role in evaluating new medical procedures, and the government's commitments to research and clinical trials. Concerns were raised about the safety and effectiveness of the procedure, the politicization of scientific research, and the appropriate role of legislation in setting medical research deadlines. There was also discussion about the establishment of a registry for patients undergoing the procedure and the membership of a scientific expert working group. The Senate also dealt with other legislative matters and procedural items, including debate on other bills and various committee reports. The debate on Bill S-204 was continued.

This artifact is a record of debate in the Senate on December 8, 2011, concerning Bill S-204, An Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). During this stage, the Senate continued its debate on the bill at second reading. A senator spoke about the challenges of Multiple Sclerosis (MS) and the potential treatment known as the "liberation procedure" related to CCSVI. The senator highlighted that while the procedure has shown promise, it is not a cure, has risks, and requires further scientific study to establish its safety and effectiveness in Canada. The senator also discussed government initiatives to fund research and establish a monitoring system. The senator expressed concern that legislating specific deadlines for this research, as proposed by the bill, might politicize the scientific process and overstep the Senate's legislative role, suggesting that inquiries are a more appropriate mechanism for urging government action. The debate on the bill was continued.

The Senate proceeded with its sitting on March 7, 2012. The sitting included routine proceedings, question period, and orders of the day. During routine proceedings, several reports from parliamentary delegations were tabled. In the question period, senators raised issues regarding Canada Summer Job Centres, the Third Optional Protocol on the Convention of the Rights of the Child, government restrictions on scientists speaking to the media, medical recommendations, and nutrition standards. The Senate also debated Bill S-8, the Safe Drinking Water for First Nations Bill, and Bill S-204, An Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). The debate on Bill S-8 was adjourned, while the debate on Bill S-204 continued. Additionally, an inquiry regarding the interference of foreign foundations in Canada's domestic affairs was debated. The Senate also authorized committees to study Canada's defence and security relationships with the United States and Canadian Forces operations in Afghanistan. A point of order was raised and a ruling was reserved, and an inquiry was withdrawn.

On April 26, 2012, the Senate debated Bill S-204, an Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). While some senators expressed support for investigating CCSVI and the Zamboni procedure, one senator argued against the bill, stating that the government was already supporting research through the Canadian Institutes of Health Research (CIHR) and that legislating scientific matters was unnecessary. The Senate agreed to move the bill to its second reading and then referred it to committee.

On November 22, 2012, the Senate was in session. During this sitting, the Social Affairs, Science and Technology Committee presented its fifteenth report concerning Bill S-204, An Act to establish a national strategy for chronic cerebrospinal venous insufficiency (CCSVI). The committee recommended that the Senate not proceed further with the bill. The report noted that while the committee shared concerns about multiple sclerosis (MS) and CCSVI, research on the link between them was inconclusive. The committee also highlighted that clinical trials were underway and that a national registry, as proposed by the bill, would be costly with little benefit. They concluded that decisions regarding CCSVI, MS, and health matters should be guided by science and medicine, not Parliament. The Senate then agreed to place the report on the Order of the Day for consideration at the next sitting. Additionally, other Senate business was conducted, including statements by Senators, tabling of committee reports on other matters, and exchanges during Question Period and Orders of the Day.